Iberogast Select (Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae Piperitae Folium, Melissae)

The four botanical extracts act together on the gastrointestinal tract. Bitter candytuft and peppermint provide spasmolytic effects by influencing calcium channels, while Matricaria and Melissa contribute anti‑inflammatory and antispasmodic actions through prostaglandin inhibition and serotonin‑receptor modulation. This synergy helps normalize motility, reduce visceral sensitivity and soothe the mucosal lining.

The appropriate dose of Iberogast Select is determined by the prescribing healthcare professional based on the individual’s age, condition severity and response to therapy. Patients should follow the prescriber’s instructions and the product label; no universal dosing regimen is provided here.

Safety data for Iberogast Select in pregnant or lactating women are limited. Because the risk cannot be ruled out, it should only be used during pregnancy or breastfeeding if the potential benefit justifies the possible risk and after consultation with a qualified healthcare provider.

To place an order, submit an enquiry on the Iberogast Select product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Iberogast Select combines four standardized extracts, offering a broader spectrum of spasmolytic, anti‑inflammatory and mucosal‑protective actions than single‑herb products such as peppermint oil alone. This multi‑component profile may provide more balanced symptom relief for functional dyspepsia and IBS, though individual response can vary and head‑to‑head clinical data are limited.

Store Iberogast Select at ambient temperature, preferably below 25 °C, in its original container. Protect the product from moisture, direct sunlight and extreme temperature fluctuations. Keep the bottle tightly closed when not in use and out of reach of children.

Iberogast Select is taken orally as a liquid preparation. The recommended method is to measure the prescribed amount using the supplied dropper or measuring device and swallow it directly or dilute with a small amount of water, as advised by the prescribing clinician.

Serious adverse reactions, although rare, include anaphylactic shock, severe hypersensitivity with swelling of the lips, tongue or throat, and potential liver enzyme elevations indicating hepatotoxicity. Patients should seek immediate medical attention if they experience any signs of a severe allergic reaction or unexplained liver‑related symptoms.

Individuals with known hypersensitivity to any of the botanical ingredients should avoid Iberogast Select. It is also not recommended for children under 12 years without medical supervision, for patients with severe liver disease, or for anyone taking medications that may interact significantly without prior professional guidance.